Classification and course of pulmonary hypertension associated with end-stage COPD
Open Access
- 27 February 2025
- journal article
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (4)
Abstract
Background: Pulmonary hypertension (PH) associated with COPD contributes to morbidity and mortality. Further characterisation to improve management is warranted. The aim of the study was to apply the recently proposed PH classification and to assess the association of lung volume involvement and PH over the course of disease in patients with advanced COPD. Methods: Patients with COPD undergoing transplant evaluation, including right heart catheterisation were included irrespective of the likelihood of having PH. Spirometry, plethysmography and computed tomography were used to assess the degree of parenchymal and vascular involvement. Follow-up investigation was performed for 18±12 months. The 2022 European Society of Cardiology/European Respiratory Society guidelines were used for classification of PH. Results: In total, 340 patients were included and 639 right heart catheters were assessed. The majority of patients were classified as no PH (n=131, 38%) or nonsevere PH (n=133, 39%), whereas severe COPD-PH was present in 26 patients (8%). Patients with severe COPD-PH had similar degrees of airflow obstruction but lower lung volumes. Further, pulmonary vascular resistance (PVR) correlated negatively with residual volume. Interstitial lung abnormalities were present in 11 patients (3%) and scattered across all PH groups. Follow-up (n=141, 41.5%) demonstrated a low rate of deterioration to severe COPD-PH (4%). However, an increase of PVR was common and was associated with a decrease of total lung capacity. Conclusion: Unbiased longitudinal invasive follow-up and assessment of lung volumes by plethysmography provided evidence of an association of lung volume and PVR.Keywords
This publication has 27 references indexed in Scilit:
- Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertensionThe Journal of Heart and Lung Transplantation, 2024
- Quantitative CT measures of pulmonary vascular volume distribution in pulmonary hypertension associated with COPD: Association with clinical characteristics and outcomesPulmonary Circulation, 2023
- Severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A prospective French multicenter cohortThe Journal of Heart and Lung Transplantation, 2021
- Quantification of Arterial and Venous Morphologic Markers in Pulmonary Arterial Hypertension Using CT ImagingChest, 2021
- Interstitial Lung Abnormalities and the Clinical Course in Patients With COPDChest, 2021
- Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner SocietyThe Lancet Respiratory Medicine, 2020
- Pulmonary Arterial Histologic Lesions in Patients With COPD With Severe Pulmonary HypertensionChest, 2019
- Is there a vanishing pulmonary capillary syndrome?The Lancet Respiratory Medicine, 2017
- Pulmonary Hypertension in Chronic Lung DiseasesJACC, 2013
- Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary diseaseThe Journal of Heart and Lung Transplantation, 2012